MiNK Therapeutics, Inc. (INKT) Ownership
INKT ownership summary
as of October 18, 2026- Institutions
- 4.0% of shares outstanding
- Insiders
- 59.69% of shares outstanding
- Shares outstanding
- 5.1M
- Float
- 2.1M shares available to trade
- Short interest
- 1.94% 50K shares short
- Days to cover
- 2.92 short interest down 13.2% vs prior month
- Institutions 4.00%
- Insiders 59.69%
- Other investors 36.31%
INKT top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard Capital Management, LLC | 1.35% | 69K | $646,091 | +9,296 (+15.7%) | June 30, 2026 |
| 2 | DnB NOR Asset Management (Asia) | 1.08% | 55K | $518,886 | +55,142 (0.0%) | June 30, 2026 |
| 3 | Longbow Finance SA | 0.33% | 17K | $156,836 | — | June 30, 2026 |
| 4 | Geode Capital Management, LLC | 0.31% | 16K | $146,542 | −1,772 (−10.2%) | June 30, 2026 |
| 5 | Citadel Advisors Llc | 0.30% | 15K | $145,290 | +15,440 (0.0%) | June 30, 2026 |
| 6 | BlackRock Inc | 0.26% | 13K | $125,925 | +7,179 (+115.7%) | June 30, 2026 |
| 7 | Vanguard Fiduciary Trust Co | 0.16% | 8,287 | $77,981 | — | June 30, 2026 |
| 8 | UBS Group AG | 0.10% | 4,885 | $45,968 | −10,317 (−67.9%) | June 30, 2026 |
| 9 | Steward Partners Investment Advisory, LLC | 0.04% | 2,000 | $18,820 | — | June 30, 2026 |
| 10 | U.S. Bancorp | 0.04% | 1,995 | $18,773 | +1,995 (0.0%) | June 30, 2026 |
| 11 | Paladin Partners, LLC | 0.02% | 1,000 | $9,410 | — | June 30, 2026 |
| 12 | Federation des caisses Desjardins du Quebec | 0.01% | 500 | $4,705 | +500 (0.0%) | June 30, 2026 |
| 13 | Tower Research Capital LLC | 0.01% | 422 | $3,971 | +266 (+170.5%) | June 30, 2026 |
| 14 | Covestor Ltd | <0.01% | 119 | $1,120 | — | June 30, 2026 |
| 15 | Advisor Group Holdings, Inc. | <0.01% | 117 | $1,101 | +116 (+11,600.0%) | June 30, 2026 |
| 16 | Morgan Stanley - Brokerage Accounts | <0.01% | 113 | $1,063 | +9 (+8.7%) | June 30, 2026 |
| 17 | Barclays PLC | <0.01% | 24 | $226 | +24 (0.0%) | June 30, 2026 |
| 18 | Mercer Global Advisors Inc. | <0.01% | 23 | $216 | +23 (0.0%) | June 30, 2026 |
| 19 | Northwestern Mutual Wealth Management Co | <0.01% | 18 | $169 | — | June 30, 2026 |
| 20 | Caitong International Asset Management Co., Limited. | <0.01% | 18 | $169 | +8 (+80.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 12 holders added 90K shares and 2 cut 12K.
INKT top mutual fund and ETF holders
9 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | DNB Fund Disrpt Opps A EUR Acc | 1.08% | 55K | $518,886 | — | August 31, 2026 |
| 2 | Vanguard MStar Total Stk Mkt Idx Invest | 1.04% | 53K | $499,389 | — | August 31, 2026 |
| 3 | Fidelity Extended Market Index | 0.13% | 6,753 | $63,546 | −36 (−0.5%) | August 31, 2026 |
| 4 | iShares Micro-Cap ETF | 0.13% | 6,426 | $60,469 | −44 (−0.7%) | September 30, 2026 |
| 5 | Fidelity Series Total Market Index | 0.06% | 2,891 | $27,204 | — | August 31, 2026 |
| 6 | Fidelity Total Market Index | 0.04% | 1,883 | $17,719 | — | August 31, 2026 |
| 7 | Fidelity Nasdaq Composite Index | 0.03% | 1,531 | $14,407 | — | August 31, 2026 |
| 8 | 1290 VT Micro Cap K | 0.01% | 445 | $4,187 | — | August 31, 2026 |
| 9 | Vanguard Balanced Index Inv | <0.01% | 208 | $1,957 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
INKT insider transactions
latest 4| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-10 | Barbara Ryan | Sell | $15.40 | 1,300 | $20,020 |
| 2026-03-09 | Barbara Ryan | Sell | $10.17 | 200 | $2,034 |
| 2026-03-02 | Barbara Ryan | Sell | $10.83 | 100 | $1,083 |
| 2026-02-27 | Barbara Ryan | Sell | $10.86 | 400 | $4,344 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
INKT shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns INKT
Institutional investors own 4.0% of MiNK Therapeutics's shares and insiders 59.69%. The largest holder is Vanguard Capital Management, LLC with 1.35% of the shares (69K), as of June 30, 2026. Among the top 20 institutions, 12 added shares and 2 reduced their stake in the latest filings. Short interest is 1.94% of the float, or 2.92 days of average trading volume. The share count rose 113.5% since 2019.
Related: INKT analyst forecast, INKT key metrics. See the INKT stock overview for the latest quote and news.
INKT ownership FAQ
Who owns the most MiNK Therapeutics stock?
The largest shareholders of MiNK Therapeutics are Vanguard Capital Management, LLC (1.35%), DnB NOR Asset Management (Asia) (1.08%), Longbow Finance SA (0.33%), Geode Capital Management, LLC (0.31%), Citadel Advisors Llc (0.30%).
What percentage of MiNK Therapeutics is owned by institutions?
Institutions hold 4.0% of MiNK Therapeutics's shares outstanding; insiders hold 59.69%.
Which funds own MiNK Therapeutics?
The largest fund holders of MiNK Therapeutics are DNB Fund Disrpt Opps A EUR Acc (1.08%), Vanguard MStar Total Stk Mkt Idx Invest (1.04%), Fidelity Extended Market Index (0.13%), iShares Micro-Cap ETF (0.13%), Fidelity Series Total Market Index (0.06%).
What is MiNK Therapeutics's short interest?
50K shares of MiNK Therapeutics were sold short, 1.94% of the float; at the average daily volume it would take 2.92 days to cover.
Are insiders buying or selling MiNK Therapeutics?
Of the latest 4 reported insider transactions in MiNK Therapeutics (since February 27, 2026), 0 were purchases and 4 were sales.
How many shares of MiNK Therapeutics are outstanding?
MiNK Therapeutics has 5.1M shares outstanding, of which 2.1M are in the public float.